About
Phinomics develops a patented platform that captures and integrates extrachromosomal circular DNA with matched multi-omic patient data to provide a complete biological understanding of cancer, enabling identification of novel therapeutic targets and resistance mechanisms.
Explore Phinomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.